<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Previous studies indicate that intravenous infusion of CGS 26303, an endothelin-converting <z:chebi fb="0" ids="23924">enzyme inhibitor</z:chebi>, prevents and reverses <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> after experimental <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Attenuation of the vasospastic response could result from enhanced production of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> via activation of endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase, neuronal nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase, or inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase in brain tissue </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="168" ids="17245">Carbon monoxide</z:chebi> has the same attenuation effect and is synthesized by inducible <z:chebi fb="4" ids="30413">heme</z:chebi>-oxygenase- 1 or constitutive <z:chebi fb="4" ids="30413">heme</z:chebi>-oxygenase-2 </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we investigated the effect of endothelin-converting <z:chebi fb="0" ids="23924">enzyme inhibitor</z:chebi> on <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase, neuronal nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase, inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase, <z:chebi fb="4" ids="30413">heme</z:chebi>-oxygenase- 1 and <z:chebi fb="4" ids="30413">heme</z:chebi>-oxygenase-2 in brain tissue of rats subjected to <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> using semi-quantitative reverse transcription-polymerase chain reaction </plain></SENT>
<SENT sid="4" pm="."><plain>The results showed that gene expression of inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase or HSP70 was not detected in <z:hpo ids='HP_0000001'>all</z:hpo> groups of rats (n = 5/group) </plain></SENT>
<SENT sid="5" pm="."><plain>Expression of endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase, neuronal nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase or <z:chebi fb="4" ids="30413">heme</z:chebi>-oxygenase-2 mRNA in brain tissue in the groups of <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> or <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> treated with endothelin-converting <z:chebi fb="0" ids="23924">enzyme inhibitor</z:chebi> appeared to be the same as compared with control rats </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> rats treated with endothelin-converting <z:chebi fb="0" ids="23924">enzyme inhibitor</z:chebi> showed a significant increase in the levels of <z:chebi fb="4" ids="30413">heme</z:chebi>-oxygenase-1 mRNA expression as compared with both <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> and control rats </plain></SENT>
<SENT sid="7" pm="."><plain>These data suggest that the reduction of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> by CGS 26303 in rats subjected to experimental <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> may result from both over-expression of <z:chebi fb="4" ids="30413">heme</z:chebi>-oxygenase-1 in brain tissue and suppression of endothelin biosynthesis in basilar arteries </plain></SENT>
</text></document>